Navigation Links
Britain’s Hearts in Good Care – Deaths Due to Heart Disease Falls by 3%

Some hearty news in the air, indeed! Today, it has been revealed that deaths due to heart disease has fallen by one-third in the past decade// and we owe this development to better awareness amongst people towards smoking, improved detection and surely, evolved treatment measures.

The data enabled by the government is evidence about the 39.5% decline in coronary heart disease deaths since 1966 for those below 75 years of age. This is half the battle won and the goal of the NHS to realize a 40% reduction in the CHD deaths by 2010 is not a distant dream.

Cholesterol restraining statins and reduction in smoking has influenced the survival rates of CHD considerably. The report named “Shaping the future” has indeed shown the impact of strategies to combat CHD on a nation that was battling a mammoth killer accounting for nearly 270,000 heart attacks each year.

The report has shown the huge strides taken in the treatment of patients, who most certainly receive treatment within the first half hour of their arrival at the hospital. In 2005, nearly 9700 lives have been brought back from critical situations with the use of statins in 2005, as compared to 2900 lives in 2000. The report also shows that waiting times for patients to undergo heart surgery has not been longer than 3 months in the previous year.
SA
'"/>




Page: 1

Related medicine news :

1. Britain’s cancer initiatives leap forward with a miracle dru
2. Britain’s Mental Health Scene Encouragin
3. Vitamin E supports Female Hearts
4. Reconstituted Blood Better For Young Hearts
5. A Call To Open Up The Channel Of Goodwill To Rescue The Dying Hearts
6. Surgeons in India to Mend ‘Pakistani Hearts’ by treating 70 Childrn
7. Novel Biological Pacemaker Under Construction for Weak Hearts
8. Murder Accused Wins Hearts By Donating An Eye
9. Heart Brakes: Hearts in European Union Invite Health Attention
10. Apollos Foray into the Hearts of Women
11. Older Donor Hearts worth Its Weight in Gold
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Britain Hearts Good Care Deaths Due Heart Disease Falls

(Date:7/31/2015)... ... 31, 2015 , ... “Engage: Don’t Just Age” will be ... leadership symposiums, hosted by Massachusetts-based Harmony Healthcare International at Foxwoods Resort Casino ... “C”-level executives, administrators, directors of nursing, rehabilitation managers and other management and corporate ...
(Date:7/31/2015)... ... 2015 , ... BioViva USA, Inc. (“BioViva”), a to-clinic gene therapy company based ... BioViva announces it has begun a fundraiser through Maximum Life Foundation (“MaxLife”) to use ... cure. MaxLife will grant 100% of the money raised to BioViva to help bring ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... The alarm was ringing. Hugh Chatfield, survivor ... out of the window, he recalled that his equipment was set up to depict the ... he jumped out of bed. , The photo speaks for itself. Chatfield is also a ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Awarded to only ... is proud to announce that they are the latest recipients of the Center ... status as one of the worldwide leaders in the science of hair transplant. , ...
(Date:7/31/2015)... ... 2015 , ... Eldermark Software, the innovative leader of senior ... Technologies (CAST) Medication Management Technologies whitepaper. The whitepaper is a compilation of three ... of using medication management technologies . , Eldermark’s case study ...
Breaking Medicine News(10 mins):Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:Prestigious Medical Award Given To Parsa Mohebi Hair Restoration for Excellence in Hair Transplantation 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3
... CEO: "This Deal Places IDE in a Key Position for ... Presence on the Australian ... TEL AVIV, Israel, August 12 IDE Technologies, jointly,owned ... Delek Group, signed a contract to supply a desalination plant ...
... Duska Therapeutics,Inc. (OTC Bulletin Board: DSKA) ("Duska") announced today ... Drug Administration,s (the "FDA"),Division of Cardiovascular and Renal Products ... with its lead drug, ATPace(TM), for the acute,treatment of ... On April 16, 2008, Duska met with the FDA ...
... distress to improve quality of life , , TUESDAY, ... increased risk for suicide, according to three new studies. ... of Washington analyzed U.S. data from 1973 to 2002 ... was 31.4 per 100,000 person-years, compared to 16.7 per ...
... MOUNTAIN VIEW, Calif., Aug. 12 MAP,Pharmaceuticals, Inc. (Nasdaq: ... June 30, 2008., The net loss for the second ... million during the same period in 2007. The net,loss for ... to $15.3,million for the first six months of 2007. As ...
... Texas, Aug. 12 American,HealthChoice, Inc. (Pink Sheets: ... clinics in Texas and Tennessee, is pleased to ... Scan, an infrared thermal imaging camera,that will be ... human body.,In conjunction with existing technologies, the OmniBody ...
... is celebrating the opening their latest location in Anderson ... services in the senior home care area. Preferred Care ... Alabama, Missouri and Minnesota. Of interest too, is that ... Anyone who has a desire to make a difference ...
Cached Medicine News:Health News:IDE Technologies Signs Contract Worth Over 100 Million Euros to Supply a Desalination Plant to Australia 2Health News:Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis 2Health News:Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis 3Health News:Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis 4Health News:Older Patients With Cancer at Heightened Suicide Risk 2Health News:MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results 2Health News:MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results 3Health News:MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results 4Health News:MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results 5Health News:MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results 6Health News:American HealthChoice Announces Launch of OmniBody Scan 2Health News:American HealthChoice Announces Launch of OmniBody Scan 3Health News:Senior Home care Providers keep Expanding Throughout the US 2Health News:Senior Home care Providers keep Expanding Throughout the US 3
(Date:7/31/2015)... Ill. , July 31, 2015 ... ® (NABP ® ) issued a report ... ensuring that action is taken against websites illegally ... Internet Drug Outlet Identification Program Progress Report ... , thousands of websites illegally distribute ...
(Date:7/31/2015)... 2015  Xcelience, a contract development and manufacturing ... a structured cash investment in Powdersize, a ... micronization and powder size classification within the pharmaceutical ... while simultaneously adding a complete set of particle ... "As we continue to build ...
(Date:7/31/2015)... -- Xencor, Inc. (NASDAQ: XNCR ), a clinical-stage biopharmaceutical ... autoimmune diseases, asthma and allergic diseases, and cancer, today ... to its board of directors. "Yujiro,s ... a tremendous asset to our board," said Bassil ... Xencor. "Xencor faces a range of opportunities for our ...
Breaking Medicine Technology:NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 3Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... Conn., Oct. 6 The Hedgeye Risk Management Healthcare team, led ... Conference Call, "Aging of America: Demographics of Demand and Profits in ... long tail of demographics, why 1994-2002 was so good, and why ... device demand, and the outlook for hip, knee, and spine device ...
... Oct. 6 Roxane Laboratories, Inc. announced today ... (ANDA) for Losartan Potassium Tablets USP, 25mg, 50mg ... Hydrochlorothiazide Tablets, 50mg/12.5mg and 100mg/25mg by the U.S. ... for immediate shipment to wholesalers and pharmacies nationwide. ...
Cached Medicine Technology:Aging of America: Demographics of Demand and Profits in Healthcare 2Roxane Laboratories, Inc. Announces the Launch of Losartan Potassium Tablets USP and Losartan Potassium and Hydrochlorothiazide Tablets 2
Colloidal Gold Sol, 20 nm - 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Colloidal Gold Sol, 20 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
CranioFix2 is the next generation CranioFix Titanium Clamp System, which is up to 40% faster than the original CranioFix and all flap fixation systems on the market....
... is an accurate, reliable, portable, and ... It works off of a dual-rechargeable ... the device a breeze. The large, ... operating and viewing results simple. Built ...
Medicine Products: